Diode Laser 940 Nm Versus Electrosurgical Device During Second Stage Implant Surgery on Bone and Soft Tissue Healing

Last updated: September 22, 2024
Sponsor: Hams Hamed Abdelrahman
Overall Status: Completed

Phase

N/A

Condition

Dental Filling

Treatment

Electrosurgical

Diode laser 940 nm

Conventional surgery

Clinical Study ID

NCT06231134
0801-11/2023
  • Ages > 25
  • All Genders

Study Summary

Background: Dental lasers and electrosurgical devices have been introduced a long time ago. However, limited studies are available concerning their use in the second stage of implant surgery, with the conventional surgical technique being the standard of care.

Aim of this study: To evaluate clinically and radiographically soft and hard tissue healing associated with the use of electrosurgical and laser devices and compare them with conventional surgical techniques during second-stage implant surgery.

Plan of the study: A randomized controlled clinical trial. The sample size will include patients who have an implant already placed and ready for second stage surgery recruited from the patient pool at the outpatient clinics.

Materials and Methods: Patients will be randomly allocated into the three groups. In Group (A) implant will be exposed using the conventional surgical exposure techniques with a tissue punch, the cover screw will be removed, and the healing abutment placed. In group (B) implant will be uncovered using a diode laser (940nm) in contact type with a continuous mode at a power of 1.5 watts, the laser tip will be used in a circular motion to create a small opening which will be increased till large enough to expose and remove the cover screw and place the healing abutments. In group (C) the monopolar electrosurgical device will be used in the same way as the laser tip with additional care avoiding contacting the implants during exposure.

The outcome: will be soft tissue healing and crestal marginal bone loss around implants.

Soft tissue healing will be assessed on the operative day, 2 weeks, and 4 weeks using Landry index. Crestal bone loss will be assessed using a standardized periapical x-ray at baseline and after 1 month with periapical x-ray.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adequate zone of keratinized mucosa.

  • Osseointegrated Implants ready for second-stage surgery.

Exclusion

Exclusion Criteria:

  • Heavy smokers due to increased risk of infection, delayed wound healing, and poorimmune response.

  • Medically compromised patients due to affection of the peri-implant health andtissue maintenance.

  • Bad oral hygiene

  • Patients with an exposed cover screw

  • Evidence of bone loss in the preoperative peri-apical radiograph.

Study Design

Total Participants: 33
Treatment Group(s): 3
Primary Treatment: Electrosurgical
Phase:
Study Start date:
November 30, 2023
Estimated Completion Date:
January 30, 2024

Connect with a study center

  • Alexandria Faculty of Dentistry

    Alexandria,
    Egypt

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.